Navigation Links
New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohn's Patients
Date:10/26/2009

s adverse events (SAEs) was 5.6 percent, including one case each of tuberculosis, pyelonephritis, and pneumonia.

About Crohn's Disease

Crohn's disease is a chronic, progressive, destructive disorder that causes inflammation of the gastrointestinal (GI) tract, most commonly at the end of the small intestine (the ileum) and beginning of the large intestine (the colon). The inflammation may be caused by the presence of high levels of Tumor Necrosis Factor (TNF) found in people with Crohn's disease. If not effectively treated, it may result in the need for surgery and hospitalization. Crohn's disease has been estimated to affect as many as half a million Americans. People with Crohn's can experience an ongoing cycle of flare-up and remission throughout their lives. Together with ulcerative colitis, Crohn's disease is an inflammatory bowel disease (IBD).

About CIMZIA® (certolizumab pegol)

CIMZIA is the only PEGylated anti-TNF (Tumor Necrosis Factor). CIMZIA( )has a high affinity for human TNF-alpha, selectively neutralising the pathophysiological effects of TNF-alpha. Over the past decade, TNF-alpha has emerged as a major target of basic research and clinical investigation. This cytokine plays a key role in mediating pathological inflammation, and excess TNF-alpha production has been directly implicated in a wide variety of immunological diseases. The U.S. Food and Drug Administration (FDA) has approved CIMZIA for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderate to severe active disease who have had an inadequate response to conventional therapy and for the treatment of adults with moderately to severely active rheumatoid arthritis (RA). CIMZIA was approved in Switzerland for induction of a clinical response and for the maintenance of a clinical response and remission in patients with active Crohn's disease who have not responded adequately to co
'/>"/>

SOURCE UCB
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
2. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
3. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
4. Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohns Disease
5. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
6. e-Zassi.com Provides Industry With Online U.S. FDA Regulatory Calculator for Rapid Medical Device Technology Assessment
7. Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback
8. New ALS Patient Simulator Advanced Provides Valuable Training for EMS Teams and In-Hospital Emergency Personnel
9. CardioGenics Holdings Inc. Provides Update on FINRA Submission Regarding Name Change
10. Young Innovations, Inc. Provides Third Quarter Conference Call Details
11. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... CHAPEL HILL, N.C. , June 18, 2013 /PRNewswire/ ... and more difficult for Medical Education groups at large ... practitioners on the safe and effective use of their ... within the pharma industry, it is crucial that these ... of reaching healthcare professionals. To address the ...
(Date:6/18/2013)... , June 18, 2013 Unilife Corporation ("Unilife" ... designer, developer and manufacturer of injectable drug delivery systems, ... at www.unilife.com . The new site includes additional ... to occur on a regular basis. Mr. ... "As an emerging global leader for injectable drug delivery ...
(Date:6/18/2013)... 18, 2013  Specialty Coating Systems is ... Parylene coating technologies: SCS microRESIST™ Antimicrobial Parylene ... Parylene with antimicrobial properties to effectively eliminate ... (Logo: http://photos.prnewswire.com/prnh/20130618/DE33772LOGO ) ... and continue to pose a challenge to ...
Breaking Medicine Technology:Though Vital to Educating Doctors on New Products, Pharma "Med Ed" Groups Working Under Huge Internal & External Constraints 2Unilife Launches New Corporate Website 2Specialty Coating Systems Announces New Antimicrobial Parylene Technology 2
... March 5 A study published by Deborah ... the Journal of Drugs in Dermatology ... resurfacing technologies, specifically, the SmartXide DOT(TM) laser. DOT utilizes ... for rapid healing, less downtime and profound results. Dr. ...
... Complications Reported With Coronary DeviceDOYLESTOWN, Pa., March 4 ... in February by completing the enrollment of 30 ... clinical trial for the vProtect(TM) Luminal Shield, conducted ... Shield successfully crossed all target lesions and was ...
Cached Medicine Technology:New Study Published in the Journal of Drugs in Dermatology Finds DOT Microablative CO2 Laser Optimum for Skin Rejuvenation 2Prescient Medical Achieves Milestones in Clinical Studies of vProtect(TM) Luminal Shield 2
(Date:6/18/2013)... has shown that cancer cells have a much different ... Now, scientists at The University of Texas at Dallas ... new strategy to combat lung cancer. , In an ... PLOS ONE , UT Dallas researchers compared the metabolic ... cells taken from the same patient. , They ...
(Date:6/18/2013)... The July 2013 issue of Marie Claire magazine in ... offers a list of home and doctor’s office treatments to ... suit this summer. The list includes treatment options for ... , and more. (go to goo.gl/aIe4J). , “It’s a helpful ... Hills, “though I would say some of the advice offered ...
(Date:6/18/2013)... Destin, FL (PRWEB) June 18, 2013 ... coast by storm. The burgeoning aquaculture industry is redefining ... Jekyll, one of the most acclaimed personal culinary chefs ... his clientele on benefits of sustainable seafood and the ... used in abundance these days. Many consumers strive to ...
(Date:6/18/2013)... By studying one of the most successful ... of successful strategies in his article What We Can ... Study. , The inspirational brand Gollan refers to is ... an impressive 62 million followers (and rising). , The ... Facebook Pages earlier this year. The Facebook data tracking publication ...
(Date:6/18/2013)... June as Lesbian, Gay, Bisexual and Transgender ... civil rights, sexual minority youth are still ... heterosexual peers, according to the Suicide Prevention ... graduate student recently published recommendation to improve ... could help improve psychological functioning and reduce ...
Breaking Medicine News(10 mins):Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:Skin Care – Getting Your Body Beach Ready 2Health News:New $119 Million Industry Swimming Up the East Coast 2Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 2Health News:Casey Gollan Shows What We Can Learn From One of the Best Facebook Pages There Is 3Health News:Sexual minority youth need specialized treatment from therapists 2
... University of California, San Diego (UCSD) School of Medicine ... that, 30 years ago, a virus infected the strep ... bacteria that has evolved to produce serious human infections ... has risen dramatically in the last three decades, and ...
... ride of Dr.Mohammed Haneef, the man from Bangalore in southern ... a heavy price for a small act of indiscretion, it looks ... his cousins, the key players in the failed Glasgow bombing. ... India, two days after the Glasgow incident, Haneef has been seeing ...
... found that symptoms in patients with obstructive sleep apnea ... with nasal insufflation (TNI), using a nasal cannula to ... ,Our findings provide evidence that TNI may ... hypopneas and apneas, said lead researcher Hartmut Schneider, M.D., ...
... 5 in North Yorkshire, troubled rocker Pete Doherty got into ... . , ,The Babyshambles singer boarded a blue ... they spotted him chucking garbage out of the window in ... troubled rocker looked really sheepish and embarrassed, and that the ...
... follow, the Varanavasi Village Panchayat near Kanchipuram in Tamil ... villagers . ,Aghast over an ever-increasing trend ... resolution to ban the entry and consumption of tobacco ... started consuming tobacco products like cigarette and gutka. Hence, ...
... Leading US drug manufacturer, Jazz Pharmaceuticals, has agreed to ... claims that one of its subsidiaries illegally marketed ... ,Narcolepsy is a sleep disorder marked by sudden, uncontrollable ... at inappropriate times. ,,The case is the ...
Cached Medicine News:Health News:Key Mechanism to Emergence of Strep Bacteria 2Health News:Key Mechanism to Emergence of Strep Bacteria 3Health News:Haneefs Visa Revoked by Australia 2Health News:Nasal Cannula Treatment for Sleep Apnea Patients 2Health News:Nasal Cannula Treatment for Sleep Apnea Patients 3Health News:Village Panchayat in Tamil Nadu Bans Tobacco Consumption 2Health News:Manufacturer to Pay $20 Million for Improperly Promoting a Sleep Disorder Drug 2Health News:Manufacturer to Pay $20 Million for Improperly Promoting a Sleep Disorder Drug 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: